Japanese company profile · 4005

SUMITOMO CHEMICAL COMPANY, LIMITED

English company name recorded in Japan's EDINET filer data.

Original Japanese company name: 住友化学株式会社

Name follows the English name recorded in EDINET filer data. English company name source

FY2025 · fiscal year ended March 2026Latest filing date: 2026-06-22

What does this company do?

What does this company do?

In its FY2025 public filing, SUMITOMO CHEMICAL COMPANY, LIMITED reports Agro and Life Solutions, ICT and Mobility Solutions, Advanced Medical Solutions, Essential and Green Materials, and 1 other reported businesses. The page shows business-level revenue and profit where the source disclosures support comparison.

SUMITOMO CHEMICAL COMPANY, LIMITED's largest reported business by revenue in FY2025 was Essential and Green Materials.

The business with the highest reported segment profit in FY2025 was Sumitomo Pharma.

FY2025 · fiscal year ended March 2026 · View original filing ↗ The source document may be in Japanese.

Reported company-wide figures

Company revenue
¥2.33T ↗
FY2025 · fiscal year ended March 2026
Operating profit
¥151.74B ↗
FY2025 · fiscal year ended March 2026
Comparable margin
6.5% ↗
FY2025 · fiscal year ended March 2026

IFRS · Consolidated company-wide

Company profile

Company profile

Identity

Securities code
4005
EDINET code
E00752
Corporate number
2010001071327
Listing status
Listed
Industry (EDINET filer classification)
Chemicals

Location and fiscal year

Headquarters
東京都中央区 · As filed in Japanese
Fiscal year end
3month
Latest fiscal year
FY2025
Accounting standard
IFRS
P16 data snapshot
2026-11-07

Company size

Employees (consolidated)
27,491 people (FY2025)
Employees (non-consolidated)
6,465 people (FY2025)
Capital stock
JPY 90.2 billion (FY2025)

Official information

Public information is organized and presented by P16. EDINET filer list (2026-11-07) Opens in a new tab · EDINET PDL 1.0 terms Opens in a new tab

Business structure

How does it make money?

Revenue leader and profit leader

RevenueEssential and Green Materials

ProfitSumitomo Pharma

FY2025 · fiscal year ended March 2026 · Business Revenue from external customers Segment profit (loss)
BusinessRevenue from external customersShare of company salesSegment profit (loss)Margin
Essential and Green Materials¥678.8B ↗—¥14.45B ↗2.1%
ICT and Mobility Solutions¥574.16B ↗—¥53.04B ↗9.2%
Agro and Life Solutions¥519.26B ↗—¥56.33B ↗10.8%
Sumitomo Pharma¥451.93B ↗—¥108.44B ↗24.0%
Advanced Medical Solutions¥58.6B ↗—¥2.82B ↗4.8%

All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended March 2026. Revenue and profit are shown only where the filing and data support a comparison. “—” means a comparable amount was not disclosed. We compare sales to outside customers for each business and the company as a whole, using the same filing, fiscal year and scope. Reported business sales may include sales between businesses. We leave the share blank when the figures cannot be matched.

Company revenue

Company-wide trend

Company revenue

IFRS · Consolidated
  1. FY202195.5¥2.77T
  2. FY2022100.0¥2.9T
  3. FY202384.5¥2.45T
  4. FY202490.0¥2.61T
  5. FY202580.4¥2.33T

Company operating profit

IFRS · Consolidated
  1. FY202144.0¥215B
  2. FY20226.3−¥30.98B
  3. FY2023100.0−¥488.83B
  4. FY202439.5¥193.03B
  5. FY202531.0¥151.74B

Only reported years are shown. Missing years are left blank; accounting standards and scopes are kept in separate series.

What has changed?

Businesses reported in earlier filings

Reporting labels alone do not prove that a business started, ended, merged, or changed its identity.

  • PetrochemicalsFY 2021 · Source
  • Energy and Functional MaterialsFY 2021–FY 2023 · Source
  • Information and Electronic ChemicalsFY 2021–FY 2023 · Source
  • Health and Crop Sciences BusinessFY 2021–FY 2023 · Source
  • PharmaceuticalsFY 2021–FY 2023 · Source
  • Essential ChemicalsFY 2022–FY 2023 · Source

Reported Revenue from external customers by business over time

Reported Revenue from external customers by business over time

Fiscal yearFY2021FY2022FY2023FY2024FY2025
Agro and Life Solutions———¥540.22B¥519.26B
ICT and Mobility Solutions———¥607B¥574.16B
Advanced Medical Solutions———¥62.15B¥58.6B
Essential and Green Materials———¥899.03B¥678.8B
Sumitomo Pharma———¥398B¥451.93B
Petrochemicals¥842.51B¥852.92B¥773.98B——
Energy and Functional Materials¥316.39B¥342.46B¥300.26B——
Information and Electronic Chemicals¥473.74B¥431.22B¥414.15B——
Health and Crop Sciences Business¥473.78B¥598.39B¥545.97B——
Pharmaceuticals¥591.71B¥584.87B¥342.74B——
Essential Chemicals¥842.51B¥852.92B¥773.98B——

All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.

What is growing?

What is growing?

Business revenue growth

This describes a reported period; it is not a forecast.

What has changed?

What has changed?

A five-year business-mix comparison is not shown because the available filings do not provide five comparable years on the same basis.

Source

Company profile

These scores summarize company characteristics using public filings. Comparison groups vary by measure. Higher is not always better.

  • Growth7
    Position among all companies with available values in the fixed reference data.FY2021→FY2025
  • Profitability54
    Position among all companies with available values in the fixed reference data.FY2025
  • Business concentration—
    No comparable data
  • Business change—
    No comparable data
  • Cash generation—
    No comparable data
  • Growth persistence19
    Peer-position scoreFY2021→FY2022, FY2022→FY2023, FY2023→FY2024, FY2024→FY2025

Next

Ask about this company

Source

Public filing

FY2025 · fiscal year ended March 2026

The source document may be in Japanese.

Filing ID: S100YAUO

View original filing ↗

根拠となる資料